OIG Finds Medicare Overpaying for Continuous Glucose Monitors; Recommends Payment Cuts
The OIG report supports CMS's recent proposal to include CGMs in the Competitive Bidding Program as a means to reduce overpayments. It also emphasizes addressing improper billing practices by suppliers using inaccurate codes that contribute to inflated Medicare costs. CMS has agreed with the OIG’s findings and recommendations, signaling forthcoming regulatory actions to optimize Medicare expenditures on CGMs and related supplies.